Verition Fund Management
RVMD icon

Verition Fund Management’s Revolution Medicines RVMD Stock Holding History

Verition Fund Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-50,000
Closed -$1.43M – 2951
2023
Q4 		$1.43M Buy
+50,000
New +$1.2M 0.01% 1005

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Verition Fund Management's RVMD Position: Q1 2026 in Review

Verition Fund Management reduced its Revolution Medicines (RVMD) stake by 42% in Q1 2026, selling an estimated $8.01M and leaving 110,000 shares worth $10.7M. The position accounts for 0.07% of the portfolio, ranked #301.

Verition Fund Management first reported a position in RVMD in Q3 2023 and has held it in 7 quarters since. The position peaked at $15.1M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Verition Fund Management held 110,000 shares of Revolution Medicines worth $10.7M as of Q1 2026.
  • Verition Fund Management sold 79,333 Revolution Medicines shares in Q1 2026, an estimated $8.01M.
  • Revolution Medicines made up 0.07% of Verition Fund Management's portfolio in Q1 2026, its #301 holding.
  • Verition Fund Management first reported a position in Revolution Medicines in Q3 2023 and has held it in 7 quarters since.
  • Verition Fund Management's Revolution Medicines position peaked at $15.1M in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.